# Multimodal Al for Precision Diagnosis of Esophageal Cancer

> **NCT07629921** · — · TERMINATED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 264 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **OTHER:** NAT
- **OTHER:** ESD
- **OTHER:** surgery

## Key facts

- **NCT ID:** NCT07629921
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-06-07
- **Target enrollment:** 264 (ACTUAL)
- **Why stopped:** local ethics review
- **Last updated:** 2026-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07629921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07629921, "Multimodal Al for Precision Diagnosis of Esophageal Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07629921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*